Patents Assigned to GENUS LIFESCIENCES INC.
  • Patent number: 11766441
    Abstract: Stable oral liquid compositions including chlorpromazine or a pharmaceutically acceptable salt or solvate of chlorpromazine, and methods of administering the compositions, are disclosed.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: September 26, 2023
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Vaishnavi Parikh, Suhas Gumaste
  • Patent number: 11737986
    Abstract: Thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: August 29, 2023
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Shivaji Phadke, Vaishnavi Parikh
  • Patent number: 11712420
    Abstract: Thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: August 1, 2023
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Shivaji Phadke, Vaishnavi Parikh
  • Patent number: 11426413
    Abstract: Stable oral liquid compositions including chlorpromazine or a pharmaceutically acceptable salt or solvate of chlorpromazine, and methods of administering the compositions, are disclosed.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: August 30, 2022
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Vaishnavi Parikh, Suhas Gumaste
  • Patent number: 11071739
    Abstract: Stable oral liquid compositions including chlorpromazine or a pharmaceutically acceptable salt or solvate of chlorpromazine, and methods of administering the compositions, are disclosed.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: July 27, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Vaishnavi Parikh, Suhas Gumaste
  • Patent number: 11040032
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: June 22, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10987347
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: April 27, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10973811
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: April 13, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10933060
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: March 2, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10894012
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: January 19, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10857095
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 8, 2020
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10603283
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising acetylsalicylic acid, or pharmaceutically acceptable salt thereof, and omeprazole, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: March 31, 2020
    Assignee: GENUS LIFESCIENCES, INC.
    Inventor: John R. Plachetka
  • Patent number: 10420760
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: September 24, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10413505
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 17, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10406108
    Abstract: Novel thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: September 10, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Shivaji Phadke, Vaishnavi Parikh
  • Patent number: 10231961
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: March 19, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 10231931
    Abstract: Novel thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: March 19, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Shivaji Phadke, Vaishnavi Parikh
  • Patent number: 10016407
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: July 10, 2018
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Patent number: 9867815
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: January 16, 2018
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman